Evidence map›Paper›PMID 33192216›Full record

ReviewEXCLI journal2020

A review on biogenic synthesis, applications and toxicity aspects of zinc oxide nanoparticles.

Rajat Sharma, Rajni Garg, Avnesh Kumari

Open access · greenAbstract readReview
In one paragraph

Review in EXCLI journal, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
4.4field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 83 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Nanomaterials (Basel, Switzerland) · 2022
    Article
  11. Zinc Oxide Nanoconjugates against Brain-Eating Amoebae.Antibiotics (Basel, Switzerland) · 2022
    Article
  12. Review
  13. Article
  14. Article
  15. Zinc oxide nanoparticles fromSaudi journal of biological sciences · 2021
    Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Rajat SharmaDepartment of Chemistry, Rayat Bahra University, Mohali, Punjab, 140301, India.
Rajni GargDepartment of Chemistry, Rayat Bahra University, Mohali, Punjab, 140301, India.
Avnesh KumariBiotechnology Division, CSIR-Institute of Himalayan Bioresource Technology, Palampur, H.P., 176061, India.
Rayat Bahra University · INInstitute of Himalayan Bioresource Technology · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nanoparticles (NPs) have become an important field of research over the past several decades with applications in various sectors, such as biomedical, cosmetic, food and many others, because of their unique characteristics. The green synthesis of nanoparticles has been preferred because of the naturally occurring reductants present in biological systems that decreases exposure to toxic chemicals compared with physico-chemical methods and is eco-friendly. Zinc oxide (ZnO) NPs exhibit broad and potential applications in different fields with their specific characteristics such as surface area, size, shape, low toxicity, optical properties, high binding energy and large band gap. This paper focuses on the bio-synthesis of ZnO NPs by utilizing extracts of different plant parts (stem, flower, fruit, peel, and leaves) through efficient, economical, simple, pure, and eco-friendly green routes. In this process, zinc salts have been used as precursor and phytochemicals in the plant extract reduce the metal salt to lower oxidation state as well as stabilize the ZnO NPs. The morphological and physico-chemical properties of obtained NPs analyzed by various characterization techniques have been discoursed. Further, antimicrobial activity and potential photocatalytic application in terms of the degradation of dyes have also been reviewed in addition to the toxicity aspects of these NPs on human beings and animals.

Indexed as

biogenic synthesisnanoparticles, degradationnanotechnologytoxicity

Identifiers

PMID33192216
PMCPMC7658464
OpenAlexW3101629064

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.